More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$248965059
EPS
0.94
P/E ratio
31.4
Price to sales
3.72
Dividend yield
--
Beta
0.258644
Previous close
$29.55
Today's open
$29.75
Day's range
$28.82 - $30.10
52 week range
$17.73 - $35.56
CEO
James L. Cunniff
Employees
174
Headquarters
New Prague, MN
Exchange
NYSE American
Shares outstanding
8340538
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Wall Street Analysts See a 36.98% Upside in Electromed (ELMD): Can the Stock Really Move This High?
The consensus price target hints at a 37% upside potential for Electromed (ELMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks Investment Research • Dec 1, 2025

3 Reasons Why Growth Investors Shouldn't Overlook Electromed (ELMD)
Electromed (ELMD) possesses solid growth attributes, which could help it handily outperform the market.
Zacks Investment Research • Dec 1, 2025

Electromed, Inc. to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference
New Prague, Minnesota--(Newsfile Corp. - November 20, 2025) - Electromed, Inc. (NYSE American: ELMD) ("Electromed" or the "Company"), a leader in innovative airway clearance technologies, today announced that it will participate in NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference being held at Florida Atlantic University in Boca Raton, Florida, on Wednesday, December 3, 2025. Jim Cunniff, Electromed's President and Chief Executive Officer, will present at 5:00 pm ET.
Newsfile Corp • Nov 20, 2025

Best Momentum Stock to Buy for Nov. 17th
ROKU, NRIM and ELMD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 17, 2025.
Zacks Investment Research • Nov 17, 2025

Wall Street Analysts Think Electromed (ELMD) Could Surge 39.17%: Read This Before Placing a Bet
The consensus price target hints at a 39.2% upside potential for Electromed (ELMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks Investment Research • Nov 14, 2025

Electromed (ELMD) Upgraded to Buy: Here's Why
Electromed (ELMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks Investment Research • Nov 14, 2025

Is Electromed (ELMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
Electromed (ELMD) could produce exceptional returns because of its solid growth attributes.
Zacks Investment Research • Nov 14, 2025

Electromed, Inc. (ELMD) Q1 2026 Earnings Call Transcript
Electromed, Inc. ( ELMD ) Q1 2026 Earnings Call November 12, 2025 5:00 PM EST Company Participants James Cunniff - President, CEO & Director Brad Nagel - CFO, Treasurer & Secretary Conference Call Participants Mike Cavanaugh Kyle Bauser - ROTH Capital Partners, LLC, Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Presentation Operator Greetings, and welcome to the Electromed First Quarter Fiscal 2026 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Seeking Alpha • Nov 12, 2025

Electromed, Inc. Announces First Quarter Fiscal 2026 Results
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed Reports First Quarter Fiscal 2026 Results.
Business Wire • Nov 12, 2025

Electromed, Inc. (ELMD) Surpasses Q1 Earnings and Revenue Estimates
Electromed, Inc. (ELMD) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.16 per share a year ago.
Zacks Investment Research • Nov 13, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Electromed Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.